In a word, the mutation of the RNF213 p.R4810K is an important factor leading to pathological abnormalities of PAH in MMD, but the specific mechanism of the effect on pulmonary vascular and cerebrovascular needs to be further studied. This evidence concerns the gene RNF213 and pulmonary arterial hypertension.